Gujarat Kidney and Super Speciality Limited has successfully completed the dispatch of its postal ballot notice to shareholders, seeking approval for strategic reallocation of Initial Public Offering (IPO) proceeds and other corporate governance matters. The company announced the completion of notice dispatch through newspaper publications on March 26, 2026.

IPO Fund Reallocation Proposal

The primary resolution involves reallocating unutilized IPO funds totaling ₹3,692.50 lakhs across two key areas. The company has already utilized ₹20,584.44 lakhs, representing 82.08% of the total IPO proceeds of ₹25,080.00 lakhs, with ₹4,495.56 lakhs remaining unutilized.

Fund Utilization Changes

Strategic Shift to Multi-Specialty Hospital

The board proposes redirecting ₹3,010.00 lakhs from establishing a women's healthcare facility in Vadodara to developing a multi-specialty hospital in Bharuch through a newly incorporated private company. The company cites the absence of modern hospitals with world-class infrastructure in Bharuch as the primary rationale for this strategic shift.

The healthcare expansion aligns with India's rapidly growing healthcare market, driven by urbanization, lifestyle diseases, and an aging population. The company anticipates strong profit margins with capital expenditure recovery expected by the third operational year for well-managed healthcare startups.

Dialysis Services Initiative

The second major reallocation involves ₹682.50 lakhs originally designated for robotics equipment purchase. These funds will now support establishing dialysis services through deployment of dialysis machines and digital patient monitoring solutions via collaboration with Lord's Mark Industries Limited.

The board emphasizes the increasing prevalence of chronic kidney disease (CKD) and related renal disorders, creating urgent demand for dialysis facilities. This initiative addresses life-sustaining medical requirements while ensuring affordable and accessible treatment for patients, particularly those from economically weaker sections.

Postal Ballot Process and Timeline

The company completed dispatch of electronic copies of the postal ballot notice along with explanatory statement on March 25, 2026, to shareholders whose names appear on the register as of the cut-off date of March 20, 2026. The notice was published in Western Times (English) and a Gujarati language newspaper on March 26, 2026.

Key Voting Details

Financial Statement Revision

The postal ballot includes approval for voluntary revision of financial statements and board reports for three preceding financial years ended March 31, 2022, 2023, and 2024. The National Company Law Tribunal (NCLT), Ahmedabad, approved this revision on February 6, 2026, through order in petition CP/23(AHM)2025.

The revision ensures proper disclosure and compliance with applicable laws and accounting standards, providing greater transparency in the company's financial position presentation.

Secretarial Auditor Appointment

Shareholders will vote on appointing Mr. Dharmendra Bhaliya, Practising Company Secretary (COP Number: 26448 and Peer Review No. 7668/2026), as Secretarial Auditor for FY 2025-26. The proposed remuneration is ₹1,20,000 plus applicable taxes and out-of-pocket expenses.

The company has engaged MUFG Intime India Private Limited to provide remote e-voting facility. Only electronic voting is permitted, with no physical postal ballot forms being distributed in compliance with Ministry of Corporate Affairs circulars. The board recommends all resolutions for shareholder approval, noting that none of the directors, key managerial personnel, or their relatives have any financial interest in the proposed resolutions except through their shareholdings in the company.

Gujarat kidney and super speciality Limited has completed the acquisition of Parekhs Hospital Private Limited as a wholly owned subsidiary on March 22, 2026. The company informed the stock exchanges about this strategic move under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Acquisition Details

The acquisition was executed through cash consideration, marking a significant expansion in the healthcare sector for Gujarat Kidney and Super Speciality Limited.

Target Company Profile

Parekhs Hospital Private Limited, incorporated on January 13, 2006, operates as a medical and healthcare service provider with its registered office in Ahmedabad, Gujarat. The company has established itself in the healthcare sector over nearly two decades of operations.

Financial Structure

Revenue Performance

Parekhs Hospital has demonstrated consistent revenue generation over the past three financial years, showing resilience in the healthcare services market.

Strategic Rationale

The acquisition aligns with Gujarat Kidney and Super Speciality Limited's expansion strategy in the healthcare sector. According to the company's disclosure, the acquisition of 100% stake in the target company will help strengthen the company's presence in the healthcare sector and diversify its business portfolio.

The transaction does not fall within related party transactions, and no promoter or promoter group companies have any interest in the acquired entity. The acquisition required no governmental or regulatory approvals, facilitating a smooth transaction process.

Corporate Compliance

The acquisition was disclosed in accordance with regulatory requirements, with Company Secretary and Compliance Officer Niki Tiwari (Membership No. 45550) signing the disclosure document. The information has also been uploaded on the company's website at www.gujaratsuperspecialityhospital.com for stakeholder access.